Screening compound: DIDRNAIMDGALOY-MRXNPFEDSA-N

Screening compound: DIDRNAIMDGALOY-MRXNPFEDSA-N
Screening compound: DIDRNAIMDGALOY-MRXNPFEDSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
DIDRNAIMDGALOY-MRXNPFEDSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S049-0556

Molecular Formula

C22H21N5O4 (C22 H21 N5 O4)

Compound Name

3-(3-{4-[5-(methoxymethyl)-1,2,4-oxadiazol-3-yl]phenoxy}pyrrolidine-1-carbonyl)-1H-indazole

IUPAC name

3-(3-{4-[5-(methoxymethyl)-124-oxadiazol-3-yl]phenoxy}pyrrolidine-1-carbonyl)-1H-indazole

SMILES

COCc1nc(-c(cc2)ccc2OC(CC2)CN2C(c2n[nH]c3c2cccc3)=O)no1

InChI

InChI=1S/C22H21N5O4/c1-29-13-19-23-21(26-31-19)14-6-8-15(9-7-14)30-16-10-11-27(12-16)22(28)20-17-4-2-3-5-18(17)24-25-20/h2-9,16H,10-13H2,1H3,(H,24,25)/t16-/m1/s1

InChI Key

DIDRNAIMDGALOY-MRXNPFEDSA-N

MDL Number (MFCD)

MFCD29011446

DIDRNAIMDGALOY-MRXNPFEDSA-N in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds
Targets:
  • Kinases
  • Phosphatases

References: we are preparing a list of scientific research reports with DIDRNAIMDGALOY-MRXNPFEDSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound DIDRNAIMDGALOY-MRXNPFEDSA-N?
Check Price and Availability of DIDRNAIMDGALOY-MRXNPFEDSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of DIDRNAIMDGALOY-MRXNPFEDSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for DIDRNAIMDGALOY-MRXNPFEDSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for DIDRNAIMDGALOY-MRXNPFEDSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of DIDRNAIMDGALOY-MRXNPFEDSA-N available by request